Theralase Technologies Inc. V.TLT

88% TR & 70% CR @180-days without 10 of the 12 undertreated

[ScienceFirst]

Because the last 5 treated had ALL been CR @90-days, we could also hit a CR of 70% @180-days too, assuming that they all keep their response intact when moving from 90-days to 180-days.

So you can see that we would be starting to gain consistency, durable response between 90-days and 180-days.

We would have 33 evaluable patients (instead of 28 ones):  

23 CR
6 IR

for a TR of 88% (29/33)
for a CR of 70% (23/33)

A very good chance to take to delay any cystectomy and maybe take a chance to even have a durable response.

 

[ScienceFirst]

No later than one month ago, on Feb. 23, 2023: : Girish Kulkarni M.D., Ph.D., FRCSC, Divisions of Urology and Surgical Oncology, Department of Surgery, Princess Margaret Cancer Centre, University Health Network, Professor, University of Toronto, (Toronto, Ontario, Canada), lead principal investigator of Study II stated, “Patients with BCG-Unresponsive CIS NMIBC have historically had

[N0taP00p]

Let's see how many ways we can say 2+2 =4.        3+1, 5-1, 1+4-1, 2x2, (29-12)/2 -4.5. So many ways we can get to four (BTD, Revenue, AA, whatever).   At this point, let's just wait for the data or quarterly report, shall we?  Think about an action plan for posting here IF they announce another raise and a  delay.  We'll all need the

[ScienceFirst]

N0taP00p ... Not surprisingly, you missed the essence of the post.

[Rumpl3StiltSkin]

What sort of soft-bashing wizardry is this ?? Poop...